Sample Testing

Analytical Testing for IVIG Drug Products

Intravenous immune globulin (IVIG) drugs are sterilized solutions of antibodies made from human plasma, and are used to treat primary immune deficiency and other immune-related conditions. IVIG drugs have, however, been linked to thrombotic events mediated largely by coagulation factor XI(a), which co-purifies with immune globulin as a contaminant. As a result, IVIG drug manufactures are recommended to routinely test the thrombogenicity of their IVIG product via detection of XI(a) activity in a specially designed thrombin generation assays. In addition, a myriad of testing for identity and impurities is also required for the release of an IVIG lot into the marketplace. HBS performs the following testing on IVIG drug products.

Analytical methods for IVIG

Assay Method Utility/Intended Use
Thrombin generation assay (TGA) Quantitative Test for Process-Related Impurities: Factor XIa and “Factor XIa-like” activity
Factor XIa chromogenic assay Quantitative detection of FXIa present in the sample
NAPTT Detection of active contaminant clotting Factors with thrombogenic potential
Protein G HPLC Identification/quantitation test for purity
Size exclusion HPLC (SE-HPLC) Identity/Molecular Size Distribution
SDS-PAGE, non-reduced Identification/Quantitative Test for Purity
SDS-PAGE, reduced Identification/Quantitative Test for Purity
Total protein, Bradford assay Protein concentration
Na-Caprylate Quantitative Test for Process-Related Impurity: Sodium Caprylate
Glycine Quantitative Test for Excipient: Glycine
PKA Quantitative Test for Process-Related Impurity: PKA
Plasmin Quantitative Test for Process-Related Impurity: Plasmin
Plasminogen Quantitative Test for Process-Related Impurity: Plasminogen
Anti-complement activity Quantitative Test for Process-Related Impurities:  Anti-complement antibodies
Hemagglutination for Anti-A and Anti-B Quantify levels of anti-A and anti-B antibodies
Anti-D antibodies Quantify levels of anti-D (Rh factor) antibodies
Fc Function Test Ensuring that Fc-mediated functions are maintained
IgA Assay (ELISA) Quantitative measurement of IgA contaminant
IgM Assay (ELISA) Quantitative measurement of IgM contaminant
Fibrinogen (ELISA) Quantitative measurement of Fibrinogen
IgG Sub-Class Characterization (ELISA) Ensuring distribution of IgG subclasses is maintained during purification
pH Ensure Correct pH of Drug Product
Osmolality Ensure Correct Osmolality of Drug Product

To Learn More

Contact us using the form on the right or call us at +1 (802) 878-1777 to learn more about how we can assist you with characterizing your IVIG drug product.

Contact Us

Please contact Haemtech using the form below for more information.

Please enter the following security code:
captcha